• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维肌痛:文献回顾

Fibromyalgia: revisiting the literature.

作者信息

Forbes Diane, Chalmers Andrew

出版信息

J Can Chiropr Assoc. 2004 Jun;48(2):119-31.

PMID:17549223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1840047/
Abstract

Fibromyalgia has a distinct clinical presentation. With no distinct characteristic beyond the presence of 11 or more tender points and chronic pain in all four quadrants of the body, it represents one extreme of a normal distribution of pain states. Research exploration utilizing the ACR criteria has not found solid empirical evidence to link the finding of multiple tender points to a specific pathological process. These points may be present as a concomitant finding with psychological disease states but they have not lead to further etiological understanding. Measurement of outcomes is difficult and the prognosis for patients in the specialty care setting is poor, however in the general population the prognosis is variable, and includes improvement without treatment. The success of treatments has been limited mainly to helping patients improve their ability to cope with, but not to eliminate the tender points.

摘要

纤维肌痛有独特的临床表现。除了存在11个或更多的压痛点以及全身四个象限的慢性疼痛外,没有其他明显特征,它代表了疼痛状态正态分布的一个极端情况。利用美国风湿病学会(ACR)标准进行的研究探索尚未找到确凿的经验证据将多个压痛点的发现与特定病理过程联系起来。这些压痛点可能作为心理疾病状态的伴随发现而存在,但它们并未带来对病因的进一步理解。结果的测量很困难,专科护理环境中患者的预后较差,然而在普通人群中,预后是可变的,包括未经治疗也会改善。治疗的成功主要限于帮助患者提高应对能力,但无法消除压痛点。

相似文献

1
Fibromyalgia: revisiting the literature.纤维肌痛:文献回顾
J Can Chiropr Assoc. 2004 Jun;48(2):119-31.
2
Reactivity to superficial and deep stimuli in patients with chronic musculoskeletal pain.慢性肌肉骨骼疼痛患者对浅表和深部刺激的反应性。
Pain. 2002 Dec;100(3):259-269. doi: 10.1016/S0304-3959(02)00297-X.
3
[Microcirculatory changes over the tender points in fibromyalgia patients after acupuncture therapy (measured with laser-Doppler flowmetry)].[针刺疗法后纤维肌痛患者压痛点处的微循环变化(用激光多普勒血流仪测量)]
Wien Klin Wochenschr. 2000 Jul 7;112(13):580-6.
4
More pain, more tender points: is fibromyalgia just one end of a continuous spectrum?疼痛更多,压痛点更多:纤维肌痛只是连续谱的一端吗?
Ann Rheum Dis. 1996 Jul;55(7):482-5. doi: 10.1136/ard.55.7.482.
5
Population study of tender point counts and pain as evidence of fibromyalgia.以压痛点计数和疼痛作为纤维肌痛证据的人群研究。
BMJ. 1994 Sep 17;309(6956):696-9. doi: 10.1136/bmj.309.6956.696.
6
Factors that affect the number of tender points in fibromyalgia and chronic widespread pain patients who did not meet the ACR 1990 criteria for fibromyalgia: are tender points a reflection of neuropathic pain?影响未达到美国风湿病学会1990年纤维肌痛标准的纤维肌痛和慢性广泛性疼痛患者压痛点数量的因素:压痛点是神经性疼痛的一种表现吗?
Semin Arthritis Rheum. 2006 Oct;36(2):130-4. doi: 10.1016/j.semarthrit.2006.05.002. Epub 2006 Jul 13.
7
A general population study of fibromyalgia tender points in noninstitutionalized adults with chronic widespread pain.一项针对非机构化慢性广泛性疼痛成年人的纤维肌痛压痛点的普通人群研究。
J Rheumatol. 2000 Nov;27(11):2677-82.
8
Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus.墨西哥系统性红斑狼疮患者中纤维肌痛的患病率及相关因素
Lupus. 2004;13(1):4-10. doi: 10.1191/0961203304lu480oa.
9
A critical analysis of the tender points in fibromyalgia.纤维肌痛压痛点的批判性分析
Pain Med. 2007 Mar;8(2):147-56. doi: 10.1111/j.1526-4637.2006.00203.x.
10
Recurrent pain, stress, tender points and fibromyalgia in childhood: an exploratory descriptive clinical study.儿童复发性疼痛、应激、压痛点和纤维肌痛:探索性描述性临床研究。
Acta Paediatr. 2012 Mar;101(3):283-91. doi: 10.1111/j.1651-2227.2011.02491.x. Epub 2011 Nov 17.

引用本文的文献

1
Pain sensitisation and joint inflammation in patients with active rheumatoid arthritis.活动性类风湿关节炎患者的痛觉敏感和关节炎症。
RMD Open. 2024 Mar 19;10(1):e003784. doi: 10.1136/rmdopen-2023-003784.
2
Fibromyalgia in a Patient with Cushing's Disease Accompanied by Central Hypothyroidism.患有库欣病并伴有中枢性甲状腺功能减退症的患者的纤维肌痛。
Intern Med. 2016;55(21):3185-3190. doi: 10.2169/internalmedicine.55.5926. Epub 2016 Nov 1.

本文引用的文献

1
The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire.纤维肌痛(FM)功能损害的评估:5个功能量表的拉施分析及纤维肌痛健康评估问卷的编制
J Rheumatol. 2000 Aug;27(8):1989-99.
2
A combined ischemic compression and spinal manipulation in the treatment of fibromyalgia: a preliminary estimate of dose and efficacy.缺血性按压与脊柱推拿联合治疗纤维肌痛:剂量与疗效的初步评估
J Manipulative Physiol Ther. 2000 May;23(4):225-30.
3
The association between chronic widespread pain and mental disorder: a population-based study.慢性广泛性疼痛与精神障碍之间的关联:一项基于人群的研究。
Arthritis Rheum. 2000 Mar;43(3):561-7. doi: 10.1002/1529-0131(200003)43:3<561::AID-ANR12>3.0.CO;2-O.
4
Improving the rate of classification of patients with the multidimensional pain inventory (MPI): clarifying the meaning of "significant other".提高多维疼痛量表(MPI)对患者的分类率:明确“重要他人”的含义。
Clin J Pain. 1999 Dec;15(4):290-6. doi: 10.1097/00002508-199912000-00005.
5
Here we go again: outcomes, outcomes, outcomes.又来了:结果,结果,还是结果。
Clin J Pain. 1999 Dec;15(4):241-3. doi: 10.1097/00002508-199912000-00001.
6
Management of fibromyalgia.纤维肌痛的管理
Ann Intern Med. 1999 Dec 7;131(11):850-8. doi: 10.7326/0003-4819-131-11-199912070-00009.
7
Physical and other non-pharmacological interventions for fibromyalgia.纤维肌痛的物理及其他非药物干预措施。
Baillieres Best Pract Res Clin Rheumatol. 1999 Sep;13(3):507-23. doi: 10.1053/berh.1999.0041.
8
Complementary medicine treatments for fibromyalgia syndrome.纤维肌痛综合征的补充医学疗法。
Baillieres Best Pract Res Clin Rheumatol. 1999 Sep;13(3):487-92. doi: 10.1053/berh.1999.0039.
9
Drug therapy.
Baillieres Best Pract Res Clin Rheumatol. 1999 Sep;13(3):479-85. doi: 10.1053/berh.1999.0038.
10
Is fibromyalgia a distinct clinical entity? Historical and epidemiological evidence.
Baillieres Best Pract Res Clin Rheumatol. 1999 Sep;13(3):427-36. doi: 10.1053/berh.1999.0032.